Crescent Biopharma, Inc.
CBIO
$13.41
$0.322.45%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Net Income | -24.61M | -21.79M | |||
| Total Depreciation and Amortization | 28.00K | 2.00K | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | 2.08M | 7.55M | |||
| Change in Net Operating Assets | 4.96M | -2.16M | |||
| Cash from Operations | -17.54M | -16.40M | |||
| Capital Expenditure | -586.00K | -140.00K | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -- | -- | |||
| Cash from Investing | -586.00K | -140.00K | |||
| Total Debt Issued | -- | -- | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | -- | 144.28M | |||
| Repurchase of Common Stock | -1.25M | -177.00K | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | 0.00 | 2.76M | |||
| Cash from Financing | -1.25M | 146.86M | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | -19.38M | 130.32M | |||